{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T15:47:36Z","timestamp":1765208856359,"version":"3.46.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is a rare small vessel disease marked by vision loss and neurocognitive deterioration. We sought to characterize the relatedness of the underlying retinal structure and cerebral disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants with RVCL-S underwent optical coherence tomography (OCT) and brain MRI at baseline and 2 years. Total macular volume (TMV) and central subfield thickness (CST) were generated from OCT images. Neuroimaging metrics of ischemic brain injury included white matter hyperintensity (WMH) volume, white matter microstructure (mean diffusivity), and normalized white matter volume. Associations between retinal and neuroimaging metrics were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eleven RVCL-S participants were included. Reduction in TMV was associated with reduced normalized white matter volume (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f0.021, 95% CI [0.006, 0.036],\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.0137), increased WMH volume (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u221211.0, 95% CI [\u221217.4, \u22124.0],\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.0046), and a near-significant increase in mean diffusivity (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22120.017, 95% CI [\u22120.035, \u22120.001],\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.057). CST was not associated with neuroimaging metrics. Percent change in TMV was associated with percent change in mean diffusivity (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22120.61, 95% CI [\u22121.14, \u22120.084],\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.028).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A metric of retinal structure, TMV, may provide a marker of cerebral disease severity in RVCL-S. Additional studies are needed to demonstrate whether early measures of TMV predict cerebral disease progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1724411","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T14:55:48Z","timestamp":1765205748000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal association of retinal morphology and white matter progression in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations"],"prefix":"10.3389","volume":"16","author":[{"given":"Henok","family":"Getahun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra S.","family":"Apte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson X.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mae","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Huecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kathryn Liszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slim","family":"Fellah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serguei V.","family":"Astafiev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan J.","family":"Miner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andria L.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/ng2082","article-title":"C-terminal truncations in human 3\u2032-5\u2032 DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy","volume":"39","author":"Richards","year":"2007","journal-title":"Nat Genet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/s0161-6420(88)33131-3","article-title":"Cerebroretinal vasculopathy. A new hereditary syndrome","volume":"95","author":"Grand","year":"1988","journal-title":"Ophthalmology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/brain\/aww217","article-title":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","volume":"139","author":"Stam","year":"2016","journal-title":"Brain"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.oret.2023.10.013","article-title":"Multimodal structural and functional characterization of retinal vasculopathy with cerebral leukoencephalopathy","volume":"8","author":"Wang","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e180916","DOI":"10.1172\/JCI180916","article-title":"Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study","volume":"134","author":"Wang","year":"2024","journal-title":"J Clin Invest"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"989536","DOI":"10.3389\/fneur.2022.989536","article-title":"Optical coherence tomography angiography biomarkers of microvascular alterations in RVCL-S","volume":"13","author":"Al-Nofal","year":"2022","journal-title":"Front Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1097\/WNO.0000000000001336","article-title":"Spectral domain optical coherence tomography in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel disease","volume":"42","author":"de Boer","year":"2022","journal-title":"J Neuroophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jamaophthalmol.2021.0320","article-title":"Association of retinal changes with Alzheimer disease neuroimaging biomarkers in cognitively normal individuals","volume":"139","author":"Byun","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jamaophthalmol.2018.3556","article-title":"Association of preclinical Alzheimer disease with optical coherence tomographic angiography findings","volume":"136","author":"O'Bryhim","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.18502\/jovr.v19i1.15422","article-title":"Dark adaptometry and optical coherence tomography angiography in Huntington disease","volume":"19","author":"Shah","year":"2024","journal-title":"J Ophthalmic Vis Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"843198","DOI":"10.3389\/fneur.2022.843198","article-title":"Fundus changes evaluated by OCTA in patients with cerebral small vessel disease and their correlations: a cross-sectional study","volume":"13","author":"Fu","year":"2022","journal-title":"Front Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/jon.12194","article-title":"Quantification of global cerebral atrophy in multiple sclerosis from 3T MRI using SPM: the role of misclassification errors","volume":"25","author":"Dell'Oglio","year":"2015","journal-title":"J Neuroimaging"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.neuroimage.2011.02.046","article-title":"A Bayesian model of shape and appearance for subcortical brain segmentation","volume":"56","author":"Patenaude","year":"2011","journal-title":"NeuroImage"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e2535","DOI":"10.1212\/WNL.0000000000201186","article-title":"Association of data-driven white matter hyperintensity spatial signatures with distinct cerebral small vessel disease etiologies","volume":"99","author":"Phuah","year":"2022","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/mrm.10609","article-title":"Characterization and propagation of uncertainty in diffusion-weighted MR imaging","volume":"50","author":"Behrens","year":"2003","journal-title":"Magn Reson Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e1918","DOI":"10.1212\/WNL.0000000000010659","article-title":"Lesion evolution and neurodegeneration in RVCL-S: a monogenic microvasculopathy","volume":"95","author":"Ford","year":"2020","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/s0161-6420(13)38009-9","article-title":"Early treatment diabetic retinopathy study design and baseline patient characteristics. ETDRS report number 7","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1001\/archophthalmol.2009.234","article-title":"A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 5","volume":"127","author":"Ip","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e0266974","DOI":"10.1371\/journal.pone.0266974","article-title":"Retinal biomarkers of cerebral small vessel disease: a systematic review","volume":"17","author":"Biffi","year":"2022","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40779-025-00630-2","article-title":"Clinical information prompt-driven retinal fundus image for brain health evaluation","volume":"12","author":"Tong","year":"2025","journal-title":"Mil Med Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"0633","DOI":"10.34133\/research.0633","article-title":"Retinal vascular morphology reflects and predicts cerebral small vessel disease: evidences from eye-brain imaging analysis","volume":"8","author":"Wu","year":"2025","journal-title":"Research"},{"key":"ref22","volume-title":"Anatomy, head and neck, eye","author":"Rehman","year":"2023"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1097\/ICB.0000000000000641","article-title":"Superficial and deep capillary ischemia as a presenting sign of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","volume":"12","author":"Nagiel","year":"2018","journal-title":"Retin Cases Brief Rep"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5935\/0004-2749.20200008","article-title":"Reproducibility of retinal and choroidal measurements using swept-source optical coherence tomography in patients with Parkinson's disease","volume":"83","author":"Obis","year":"2020","journal-title":"Arq Bras Oftalmol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1724411\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T14:55:48Z","timestamp":1765205748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1724411\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":24,"alternative-id":["10.3389\/fneur.2025.1724411"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1724411","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"article-number":"1724411"}}